All countries
AI in pharma market to hit $28.6b by 2034 on drug discovery push
AI in pharma market to hit $28.6b by 2034 on drug discovery push
Asia Pacific is set to post the fastest growth.
1 day ago
Gene editing market may nearly triple to $30.5b by 2033
Asia Pacific is seen as fastest-growing region.
1 day ago
Biologics boom pushes biopharma equipment market toward $116.4b
Asia-Pacific is emerging as the fastest-growing region.
2 days ago
AI-powered microscopy software poised for $3.09b surge by 2031
North America accounted for the largest market share in 2025.
3 days ago
Biomarkers market to top $112b by 2031 on drug discovery demand
Consumables held the largest share at 73.4% in 2025.
4 days ago
GERD device market to hit $1.9b as reflux care goes minimally invasive
India emerged as the fastest-growing market in APAC.
Fertility sensors race to $2.80b by 2033 as at-home testing takes off
Asia Pacific could emerge as the fastest-growing region.
Global lab filtration market to hit $6.8b by 2030 on biopharma demand
Demand for sterile and membrane filtration is expected to rise across global labs.
Pharma AI stays stuck in pilot as drugmakers chase output
Digital twins are being tested to improve existing factory capacity.
DEE market to surge almost 12% annually on gene therapy advances
Patient pool rises to 326,000 by 2036 across 7MM as diagnosis rates increase.
Alcohol-linked liver disease market to see 31% annual growth in next decade
In 2025, the market size was at $145m.
Chronic conditions fuel demand as pneumonia market expands
It is primarily driven by the ageing population.
UTI testing market to reach $78.9b by 2036 on antibiotic resistance, diagnostic demand
India and China are emerging as significant centres due ti high investment.
Capsule endoscopy market to reach $2.15b by 2033 on GI disease surge
Capsule endoscopy does not support treatment.
Apheresis market to hit $4.4b by 2031 on autoimmune, surgical demand
Asia Pacific is estimated to record the highest CAGR.
Biologics adoption to fuels trillion-dollar injectable market expansion
China and India are emerging as key manufacturing and consumption centres.
Rising elderly cancer burden to expand T-cell malignancies market
Advances in molecular profiling help improve the understanding of these diseases.
Most Read
1. Healthway Medical expands with Bridgepoint Health buy 2. AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings 3. Boustead buys 60% of UroMedTech in $6m prostate cancer bet 4. China’s healthcare defies Hang Seng slump with 0.9% gain 5. How can healthcare providers make AI pay off?Resource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
Demand was strong for AI-driven and digital healthcare solutions.
Commentary
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings
Beyond symptom control: Redefining IMID care in Malaysia
How decentralised clinical trials can unlock Asia's research potential